Elon Musk says that in a week, the new X algorithm—meaning all the code that determines what you see in your X feed—will be ...

Instagram is rolling out a new tool called Your Algorithm, and it gives you direct control over the videos that fill your Reels tab. Your interests shift as time moves on. Now your feed can shift with ...

– Positive Phase 3 Results from Both ARTISTRY-2 and ARTISTRY-1 Trials will Form the Basis of Regulatory Submissions – FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today ...

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment responses ...

– Positive Phase 3 Results from Both ARTISTRY-2 and ARTISTRY-1 Trials will Form the Basis of Regulatory Submissions – Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from ...

Researchers at Karolinska Institutet and KTH have developed a computational method that can reveal how cells change and specialize in the body. The study, which has been published in the journal PNAS, ...

new video loaded: I’m Building an Algorithm That Doesn’t Rot Your Brain transcript Jack Conte, the chief executive of Patreon, a platform for creators to monetize their art and content, outlines his ...

new video loaded: I’m Building an Algorithm That Doesn’t Rot Your Brain transcript “Our brains are being melted by the algorithm.” [MUSIC PLAYING] “Attention is infrastructure.” “Those algorithms are ...

Gilead Sciences, Inc. GILD announced that its investigational single-tablet regimen (STR) of bictegravir and lenacapavir for HIV-1 Treatment met the primary endpoint in the late-stage ARTISTRY-1 study ...

– Phase 3 Results from ARTISTRY-1 and 2 Trials will Form the Basis of Regulatory Submissions – FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) today announced positive ...